[go: up one dir, main page]

CN111574413A - A kind of preparation method of sulfonyl amidine with 2-aminomethylpyridine and DMF-DMA as amine source - Google Patents

A kind of preparation method of sulfonyl amidine with 2-aminomethylpyridine and DMF-DMA as amine source Download PDF

Info

Publication number
CN111574413A
CN111574413A CN202010510716.1A CN202010510716A CN111574413A CN 111574413 A CN111574413 A CN 111574413A CN 202010510716 A CN202010510716 A CN 202010510716A CN 111574413 A CN111574413 A CN 111574413A
Authority
CN
China
Prior art keywords
dma
dmf
sulfonyl
aminomethylpyridine
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202010510716.1A
Other languages
Chinese (zh)
Other versions
CN111574413B (en
Inventor
戴立言
赵启航
刘聪
王晓钟
陈英奇
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hangzhou Shanghe Biomedical Technology Co ltd
Zhejiang University ZJU
Original Assignee
Hangzhou Shanghe Biomedical Technology Co ltd
Zhejiang University ZJU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hangzhou Shanghe Biomedical Technology Co ltd, Zhejiang University ZJU filed Critical Hangzhou Shanghe Biomedical Technology Co ltd
Priority to CN202010510716.1A priority Critical patent/CN111574413B/en
Publication of CN111574413A publication Critical patent/CN111574413A/en
Application granted granted Critical
Publication of CN111574413B publication Critical patent/CN111574413B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/40Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reactions not involving the formation of sulfonamide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40Acylated substituent nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pyridine Compounds (AREA)

Abstract

本发明公开了一种2‑氨甲基吡啶与DMF‑DMA作为胺源的磺酰脒的制备方法,包括以下步骤:首先,以磺酰氯与2‑氨甲基吡啶反应,得中间产物;然后,中间产物与DMF‑DMA在催化剂存在下,于60~100℃反应,然后降至室温,反应液用乙酸乙酯萃取,分层,干燥后浓缩得到目标产物磺酰脒。本发明方法实现了二级磺酰胺与DMF‑DMA的反应,拓展了磺酰脒的合成路径。合成反应操作简单、条件温和、后处理方便,所得中间产物及产品的纯度和收率高。The invention discloses a preparation method of sulfonyl amidine with 2-aminomethyl pyridine and DMF-DMA as amine sources, comprising the following steps: firstly, reacting sulfonyl chloride with 2-aminomethyl pyridine to obtain an intermediate product; then , the intermediate product and DMF-DMA are reacted at 60-100 ℃ in the presence of a catalyst, and then cooled to room temperature, the reaction solution is extracted with ethyl acetate, layered, dried and concentrated to obtain the target product sulfonyl amidine. The method of the invention realizes the reaction of the secondary sulfonamide and DMF-DMA, and expands the synthesis path of the sulfonyl amidine. The synthesis reaction has simple operation, mild conditions, convenient post-processing, and the obtained intermediate products and products have high purity and yield.

Description

一种2-氨甲基吡啶与DMF-DMA作为胺源的磺酰脒的制备方法A kind of preparation method of sulfonyl amidine with 2-aminomethylpyridine and DMF-DMA as amine source

技术领域technical field

本发明属于有机中间体合成领域,具体涉及一种2-氨甲基吡啶与N,N-二甲基甲酰胺二甲基缩醛(DMF-DMA)作为胺源的磺酰脒的制备方法。The invention belongs to the field of organic intermediate synthesis, in particular to a method for preparing a sulfonyl amidine using 2-aminomethylpyridine and N,N-dimethylformamide dimethyl acetal (DMF-DMA) as amine sources.

背景技术Background technique

脒类化合物是一类重要的含氮有机物。随着N原子上取代基位置和数量变化,脒类化合物及其衍生物的物化性质也随之改变,因而其被应用于生产生活的方方面面。脒类化合物可被用于合成表面活性剂、染料、医疗药剂、杀菌剂、驱虫剂及一系列重要化合物的中间体。脒类化合物存在于许多具有生物活性的天然化合物中,故被认为是重要的医药中间体。Amidine compounds are an important class of nitrogen-containing organic compounds. With the change of the position and number of substituents on the N atom, the physicochemical properties of amidine compounds and their derivatives also change, so they are used in all aspects of production and life. Amidine compounds can be used to synthesize surfactants, dyes, medical agents, fungicides, insect repellants and intermediates for a series of important compounds. Amidine compounds exist in many natural compounds with biological activity, so they are considered as important pharmaceutical intermediates.

当碳氮双键中的N原子与磺酰基相连时,脒类化合物往往具有更高的生物活性和药理作用,因而备受科学界和产业界的关注。When the N atom in the carbon-nitrogen double bond is connected to a sulfonyl group, the amidine compounds tend to have higher biological activity and pharmacological effects, and thus have attracted much attention from the scientific and industrial circles.

目前合成磺酰脒类化合物常使用重氮盐或叠氮化合物作为胺源。如利用四氟硼酸重氮盐和磺酰胺、乙腈在1,2-二氯乙烷中反应生成磺酰脒;使用磺酰叠氮与叔胺在铜盐和四氯化碳催化下也可制得一系列磺酰脒。但重氮盐和叠氮化合物普遍不稳定、易爆炸的性质限制了此类方法的普适性。At present, diazonium salts or azide compounds are often used as amine sources for the synthesis of sulfonyl amidines. For example, using tetrafluoroborate diazonium salt and sulfonamide, acetonitrile in 1,2-dichloroethane to generate sulfonyl amidine; using sulfonyl azide and tertiary amine under the catalysis of copper salt and carbon tetrachloride can also be prepared A series of sulfonyl amidines were obtained. However, the generally unstable and explosive properties of diazonium salts and azides limit the applicability of such methods.

在采用简单的磺酰胺与酰胺作为胺源时,需要草酰氯或二氯亚砜等与酰胺制成维尔斯迈尔试剂才能顺利进行脱水反应得到磺酰脒。其不足之处在于使用草酰氯需过量,使用二氯亚砜则会产生二氧化硫气体。When simple sulfonamide and amide are used as amine sources, oxalyl chloride or thionyl chloride, etc. and amide are required to make Wilsmeier reagent to successfully conduct dehydration reaction to obtain sulfonyl amidine. The disadvantage is that the use of oxalyl chloride needs to be excessive, and the use of thionyl chloride will generate sulfur dioxide gas.

发明内容SUMMARY OF THE INVENTION

本发明克服了上述路线胺源单一的缺陷,提出了一种环境较为友好的磺酰脒类化合物的制备方法。即通过2-氨甲基吡啶与对甲苯磺酰氯反应制得N-(2-吡啶甲基)对甲苯磺酰胺后,实现二级磺酰胺与DMF-DMA(N,N-二甲基甲酰胺二甲基缩醛)反应制备对甲苯磺酰脒。The present invention overcomes the defect of single amine source of the above route, and proposes a preparation method of sulfonyl amidine compounds which is more environmentally friendly. That is, after the reaction of 2-aminomethylpyridine and p-toluenesulfonyl chloride to prepare N-(2-pyridylmethyl)-p-toluenesulfonamide, the secondary sulfonamide and DMF-DMA (N,N-dimethylformamide are realized) dimethyl acetal) to prepare p-toluenesulfonyl amidine.

为解决上述技术问题,本发明提供的技术方案如下:In order to solve the above-mentioned technical problems, the technical solutions provided by the present invention are as follows:

一种2-氨甲基吡啶与DMF-DMA作为胺源的磺酰脒的制备方法,包括:磺酰氯与2-氨甲基吡啶在有机碱存在下,反应得到的中间体再与DMF-DMA在催化剂存在下反应得到磺酰脒;A preparation method of sulfonyl amidine with 2-aminomethyl pyridine and DMF-DMA as amine source, comprising: sulfonyl chloride and 2-aminomethyl pyridine in the presence of an organic base, reacting the intermediate obtained with DMF-DMA In the presence of a catalyst, the reaction obtains the sulfonyl amidine;

所述磺酰氯、中间体以及磺酰脒的结构分别如下式所示:The structures of the sulfonyl chloride, the intermediate and the sulfonyl amidine are respectively shown in the following formulas:

Figure BDA0002528125010000021
Figure BDA0002528125010000021

R1选自C1-C5的烷基;C1-C5的烷氧基;卤素原子;氢原子。R 1 is selected from a C1-C5 alkyl group; a C1-C5 alkoxy group; a halogen atom; a hydrogen atom.

R2,R3各自独立的选自C1-C5的烷基;氢原子。R 2 and R 3 are each independently selected from C1-C5 alkyl groups; hydrogen atoms.

作为优选,所述R1选自叔丁基、甲基、乙基、甲氧基、乙氧基,溴原子、氢原子;所述R2,R3各自独立的选自甲基、氢原子。Preferably, the R 1 is selected from tert-butyl group, methyl group, ethyl group, methoxy group, ethoxy group, bromine atom and hydrogen atom; the R 2 and R 3 are independently selected from methyl group and hydrogen atom. .

作为优选,一种2-氨甲基吡啶与DMF-DMA作为胺源的磺酰脒的制备方法,包括:As preferably, a kind of preparation method of the sulfonyl amidine of 2-aminomethylpyridine and DMF-DMA as amine source, comprises:

(1)向溶剂I中加入磺酰氯,溶解得到磺酰氯溶液;将2-氨甲基吡啶和有机碱的混合物滴加到上述磺酰氯溶液中,反应完毕,经后处理得中间体;(1) in solvent 1, add sulfonyl chloride, dissolve to obtain sulfonyl chloride solution; The mixture of 2-aminomethylpyridine and organic base is added dropwise in the above-mentioned sulfonyl chloride solution, the reaction is completed, and the intermediate is obtained through aftertreatment;

(2)将步骤(1)得到的中间体、DMF-DMA、催化剂与溶剂II混合,反应,后处理得磺酰脒。(2) Mix the intermediate, DMF-DMA, catalyst and solvent II obtained in step (1), react, and post-process to obtain the sulfonyl amidine.

具体讲:本发明以2-氨甲基吡啶、磺酰氯为原料,制备磺酰脒,包括以下步骤:Specifically: the present invention uses 2-aminomethylpyridine and sulfonyl chloride as raw materials to prepare sulfonyl amidine, comprising the following steps:

(1)向一定量的溶剂I中加入磺酰氯,并于室温条件下搅拌溶解;在另一反应瓶中加入2-氨甲基吡啶和有机碱,再缓慢滴加到上述磺酰氯溶液中,反应4~8h;反应完毕,经过旋蒸、冰水洗涤、过滤、烘干得中间体;(1) in a certain amount of solvent I, add sulfonyl chloride, and stir and dissolve at room temperature; In another reaction flask, add 2-aminomethylpyridine and organic base, then slowly drip into the above-mentioned sulfonyl chloride solution, The reaction is carried out for 4 to 8 hours; after the reaction is completed, the intermediate is obtained by rotary evaporation, washing with ice water, filtration and drying;

(2)将步骤(1)得到的中间体加入到溶剂II中,加入DMF-DMA,催化剂,在60~100℃下反应6~10h,降至室温后,反应液用乙酸乙酯萃取,分层,干燥,浓缩,得目标产物磺酰脒。(2) Add the intermediate obtained in step (1) into solvent II, add DMF-DMA, a catalyst, and react at 60-100° C. for 6-10 hours. After cooling to room temperature, the reaction solution is extracted with ethyl acetate, and the mixture is separated. layer, dried and concentrated to obtain the target product sulfonyl amidine.

以R为甲基、甲氧基、叔丁基、溴原子或氢原子,R2、R3为甲基或氢原子为例,上述反应过程如下式所示:Taking R as methyl group, methoxyl group, tert-butyl group, bromine atom or hydrogen atom, and R 2 and R 3 as methyl group or hydrogen atom as example, the above reaction process is shown in the following formula:

Figure BDA0002528125010000031
Figure BDA0002528125010000031

作为优选,所用磺酰氯为对甲基苯磺酰氯、对甲氧基苯磺酰氯、对叔丁基苯磺酰氯、苯磺酰氯、对溴基苯磺酰氯或均三甲基苯磺酰氯。Preferably, the used sulfonyl chloride is p-toluenesulfonyl chloride, p-methoxybenzenesulfonyl chloride, p-tert-butylbenzenesulfonyl chloride, benzenesulfonyl chloride, p-bromobenzenesulfonyl chloride or mesitylenesulfonyl chloride.

为在第一步反应中得到更多的中间产品,作为优选,2-氨甲基吡啶,磺酰氯,有机碱的摩尔比为1:1~2:1~2;作为进一步优选,2-氨甲基吡啶,磺酰氯,有机碱的摩尔比为1:1~1.3:1.5~1.7。作为优选,溶剂I和2-氨甲基吡啶的重量比为30~50:1。In order to obtain more intermediate products in the first step reaction, preferably, the molar ratio of 2-aminomethylpyridine, sulfonyl chloride, and organic base is 1:1~2:1~2; as a further preference, 2-aminomethylpyridine The molar ratio of methylpyridine, sulfonyl chloride and organic base is 1:1-1.3:1.5-1.7. Preferably, the weight ratio of solvent I and 2-aminomethylpyridine is 30-50:1.

磺酰氯与2-氨甲基吡啶反应时(或步骤(1)中),使用的溶剂(或溶剂I)优选为二氯甲烷、1,2-二氯乙烷、四氢呋喃中的一种。作为优选,磺酰氯与2-氨甲基吡啶反应时(或步骤(1)中),使用的溶剂为二氯甲烷。When the sulfonyl chloride is reacted with 2-aminomethylpyridine (or in step (1)), the solvent (or solvent I) used is preferably one of dichloromethane, 1,2-dichloroethane and tetrahydrofuran. Preferably, when the sulfonyl chloride is reacted with 2-aminomethylpyridine (or in step (1)), the solvent used is dichloromethane.

作为优选,所述的有机碱为三乙胺、三甲胺、吡啶、哌啶。作为进一步优选,所述有机碱为三乙胺。作为进一步优选,所述2-氨甲基吡啶,磺酰氯,三乙胺的摩尔比为1:1~1.3:1.5~1.7。Preferably, the organic base is triethylamine, trimethylamine, pyridine and piperidine. As a further preference, the organic base is triethylamine. As a further preference, the molar ratio of the 2-aminomethylpyridine, the sulfonyl chloride and the triethylamine is 1:1-1.3:1.5-1.7.

中间体与DMF-DMA反应时(或步骤(2)),所用溶剂(或者溶剂II)为乙二醇、异丙醇、正丙醇、正丁醇、二乙二醇中的一种或多种。作为进一步优选,所述溶剂(或溶剂II)为乙二醇。When the intermediate reacts with DMF-DMA (or step (2)), the solvent used (or solvent II) is one or more of ethylene glycol, isopropanol, n-propanol, n-butanol, and diethylene glycol. kind. As a further preference, the solvent (or solvent II) is ethylene glycol.

中间体与DMF-DMA反应时(或步骤(2)),所用的催化剂为一水合醋酸铜、氯化亚铜、氯化铜、硝酸铜、溴化铜、溴化亚铜。进一步优选为一水合醋酸铜。When the intermediate reacts with DMF-DMA (or step (2)), the catalyst used is copper acetate monohydrate, cuprous chloride, cupric chloride, cupric nitrate, cupric bromide, and cuprous bromide. More preferably, it is copper acetate monohydrate.

为尽可能多地得到产品,第二步反应中所用中间产物与催化剂的摩尔比为1:0.02~0.1,所用溶剂与中间产物的重量比为20~40:1,所用DMF-DMA与中间产物的重量比为5~30:1,进一步优选为所述DMF-DMA与中间产物的重量比为10~20:1。作为更进一步优选,所述DMF-DMA与中间产物的重量比为10~15:1。In order to obtain as many products as possible, the molar ratio of the intermediate product used in the second step reaction to the catalyst is 1:0.02~0.1, the weight ratio of the solvent used to the intermediate product is 20~40:1, the used DMF-DMA and the intermediate product are The weight ratio of the DMF-DMA to the intermediate product is 5-30:1, more preferably, the weight ratio of the DMF-DMA to the intermediate product is 10-20:1. As a further preference, the weight ratio of the DMF-DMA to the intermediate product is 10-15:1.

作为优选,所述中间体与DMF-DMA反应的溶剂为乙二醇;所述催化剂为一水合醋酸铜。反应温度为60~100℃,反应时间为6~10小时。Preferably, the solvent for the reaction between the intermediate and DMF-DMA is ethylene glycol; the catalyst is copper acetate monohydrate. The reaction temperature is 60-100°C, and the reaction time is 6-10 hours.

本发明与现有技术相比具有以下优点:Compared with the prior art, the present invention has the following advantages:

1.第一步合成中间产物的反应操作简单、条件温和、后处理方便,所得中间产物的纯度和收率高。1. The reaction operation of the first step to synthesize the intermediate product is simple, the conditions are mild, the post-processing is convenient, and the obtained intermediate product has high purity and yield.

2.利用2-吡啶甲基的特殊性,实现了二级磺酰胺与DMF-DMA的反应,进一步丰富了合成磺酰脒的方法。2. Utilizing the particularity of 2-pyridylmethyl, the reaction between secondary sulfonamide and DMF-DMA was realized, which further enriched the method for synthesizing sulfonyl amidine.

综上所述,本发明方法实现了二级磺酰胺与DMF-DMA的反应,拓展了磺酰脒的合成路径。合成反应操作简单、条件温和、后处理方便,所得中间产物及产品的纯度和收率高。To sum up, the method of the present invention realizes the reaction of the secondary sulfonamide and DMF-DMA, and expands the synthetic route of the sulfonyl amidine. The synthesis reaction has simple operation, mild conditions, convenient post-processing, and the obtained intermediate products and products have high purity and yield.

附图说明Description of drawings

图1为本发明具体实施例1中所得产品对甲苯磺酰脒的氢核磁谱图(1H-NMR),核磁数据如下:1H NMR(500MHz,DMSO-d6)δ8.19(s,1H),7.64(d,J=8.2Hz,2H),7.32(d,J=7.9Hz,2H),3.13(s,3H),2.88(s,3H),2.35(s,3H)。Fig. 1 is the hydrogen nuclear magnetic spectrum ( 1 H-NMR) of the product p-toluenesulfonyl amidine obtained in specific embodiment 1 of the present invention, and the nuclear magnetic data are as follows: 1 H NMR (500MHz, DMSO-d6)δ8.19(s,1H ), 7.64(d, J=8.2Hz, 2H), 7.32(d, J=7.9Hz, 2H), 3.13(s, 3H), 2.88(s, 3H), 2.35(s, 3H).

图2为本发明具体实施例16中所得产品对叔丁基苯磺酰脒的氢核磁谱图(1H-NMR),核磁数据如下:1H NMR(500MHz,Chloroform-d)δ8.15(s,1H),7.82(d,J=6.6Hz,2H),7.47(d,J=8.8Hz,2H),3.12(s,3H),3.02(s,3H),1.33(s,9H)。Fig. 2 is the hydrogen nuclear magnetic spectrum ( 1 H-NMR) of the product p-tert-butylbenzenesulfonyl amidine obtained in specific embodiment 16 of the present invention, and the nuclear magnetic data are as follows: 1 H NMR (500MHz, Chloroform-d) δ8.15 ( s, 1H), 7.82 (d, J=6.6 Hz, 2H), 7.47 (d, J=8.8 Hz, 2H), 3.12 (s, 3H), 3.02 (s, 3H), 1.33 (s, 9H).

图3为本发明具体实施例17中所得产品对甲氧基苯磺酰脒的氢核磁谱图(1H-NMR),核磁数据如下:1H NMR(500MHz,Chloroform-d)δ8.12(s,1H),7.81(d,J=8.9Hz,2H),6.91(d,J=8.9Hz,2H),3.84(s,3H),3.12(s,3H),3.01(s,3H)。Fig. 3 is the hydrogen nuclear magnetic spectrum ( 1 H-NMR) of the product p-methoxybenzenesulfonyl amidine obtained in specific embodiment 17 of the present invention, and the nuclear magnetic data are as follows: 1 H NMR (500MHz, Chloroform-d) δ8.12 ( s, 1H), 7.81 (d, J=8.9Hz, 2H), 6.91 (d, J=8.9Hz, 2H), 3.84 (s, 3H), 3.12 (s, 3H), 3.01 (s, 3H).

图4为本发明具体实施例18中所得产品苯磺酰脒的氢核磁谱图(1H-NMR),核磁数据如下:1H NMR(500MHz,Chloroform-d)δ8.15(s,1H),7.89(d,J=7.1Hz,2H),7.57–7.39(m,3H),3.13(s,3H),3.02(s,3H)。Fig. 4 is the hydrogen nuclear magnetic spectrum ( 1 H-NMR) of the product benzenesulfonyl amidine obtained in the specific embodiment of the present invention, and the nuclear magnetic data are as follows: 1 H NMR (500MHz, Chloroform-d) δ8.15 (s, 1H) , 7.89 (d, J=7.1 Hz, 2H), 7.57–7.39 (m, 3H), 3.13 (s, 3H), 3.02 (s, 3H).

图5为本发明具体实施例19中所得产品对溴基苯磺酰脒的氢核磁谱图(1H-NMR),核磁数据如下:1H NMR(500MHz,Chloroform-d)δ8.13(s,1H),7.75(d,J=8.6Hz,2H),7.60(d,J=8.6Hz,2H),3.15(s,3H),3.02(s,3H)。Fig. 5 is the hydrogen nuclear magnetic spectrum ( 1 H-NMR) of the product p-bromobenzenesulfonyl amidine obtained in specific embodiment 19 of the present invention, and the nuclear magnetic data are as follows: 1 H NMR (500MHz, Chloroform-d) δ8.13 (s , 1H), 7.75 (d, J=8.6 Hz, 2H), 7.60 (d, J=8.6 Hz, 2H), 3.15 (s, 3H), 3.02 (s, 3H).

图6、图7分别为本发明具体实施例20中所得产品均三甲基苯磺酰脒的氢核磁谱图(1H-NMR)和碳核磁谱图,核磁数据如下:1H NMR(500MHz,Chloroform-d)δ8.11(s,1H),6.91(s,2H),3.09(s,3H),2.99(s,3H),2.68(s,6H),2.27(s,3H)。13C NMR(126MHz,Chloroform-d)δ158.46,141.22,138.43,136.51,131.46,41.28,35.42,23.02,20.89。Fig. 6, Fig. 7 are respectively the hydrogen nuclear magnetic spectrogram ( 1 H-NMR) and carbon nuclear magnetic spectrogram of the obtained product mesitylene sulfonyl amidine in the specific embodiment of the present invention 20, and the nuclear magnetic data are as follows: 1 H NMR (500MHz) , Chloroform-d) δ 8.11(s, 1H), 6.91(s, 2H), 3.09(s, 3H), 2.99(s, 3H), 2.68(s, 6H), 2.27(s, 3H). 13 C NMR (126 MHz, Chloroform-d) δ 158.46, 141.22, 138.43, 136.51, 131.46, 41.28, 35.42, 23.02, 20.89.

具体实施方式Detailed ways

实施例1Example 1

在干燥的反应瓶中加入1.14g(6mmol)对甲苯磺酰氯及10mL二氯甲烷,室温下搅拌溶解,缓慢滴加10mL含0.54g(5mmol)2-氨甲基吡啶和0.76g(7.5mmol)三乙胺的二氯甲烷溶液,滴加完毕,室温下搅拌反应6小时。反应完毕,将反应液旋蒸浓缩,得到淡粉色固体。在冰水浴中,用去离子水充分洗涤上述淡粉色固体,过滤,烘干,得黄白色粉末1.27g,收率97%,HPLC纯度为99%。1.14g (6mmol) of p-toluenesulfonyl chloride and 10mL of dichloromethane were added to the dry reaction flask, stirred and dissolved at room temperature, and 10mL of 0.54g (5mmol) of 2-aminomethylpyridine and 0.76g (7.5mmol) of 2-aminomethylpyridine were slowly added dropwise in 10mL. The solution of triethylamine in dichloromethane was added dropwise, and the reaction was stirred at room temperature for 6 hours. After the reaction was completed, the reaction solution was concentrated by rotary evaporation to obtain a pale pink solid. In an ice-water bath, the above-mentioned pale pink solid was fully washed with deionized water, filtered and dried to obtain 1.27 g of yellow-white powder with a yield of 97% and a HPLC purity of 99%.

取一干燥的三口烧瓶,加入上述中间产品即N-(2-吡啶甲基)对甲苯磺酰胺0.66g(2.5mmol),乙二醇7.5mL,DMF-DMA7.5mL,一水合醋酸铜25mg(0.125mmol),之后升温至80℃反应8小时。反应结束,冷却至室温,加入30mL去离子水洗涤,然后用(20mL*3)乙酸乙酯萃取,合并有机层并用无水MgSO4干燥,浓缩得到黄色液体,经柱层析分离得到白色粉末0.52g,收率92%,HPLC纯度为99%。核磁数据见图1。Get a dry three-necked flask, add above-mentioned intermediate product namely N-(2-pyridylmethyl) p-toluenesulfonamide 0.66g (2.5mmol), ethylene glycol 7.5mL, DMF-DMA 7.5mL, copper acetate monohydrate 25mg ( 0.125 mmol), and then the temperature was raised to 80°C for 8 hours. The reaction was completed, cooled to room temperature, washed with 30 mL of deionized water, then extracted with (20 mL*3) ethyl acetate, the organic layers were combined and dried with anhydrous MgSO 4 , concentrated to obtain a yellow liquid, which was separated by column chromatography to obtain a white powder 0.52 g, 92% yield, 99% HPLC purity. The NMR data are shown in Figure 1.

实施例2Example 2

在干燥的反应瓶中加入1.14g(6mmol)对甲苯磺酰氯及10mL 1,2-二氯乙烷,室温下搅拌溶解,缓慢滴加10mL含0.54g(5mmol)2-氨甲基吡啶和0.76g(7.5mmol)三乙胺的1,2-二氯乙烷溶液,滴加完毕,室温下搅拌反应6小时。反应完毕,将反应液旋蒸浓缩,得到淡粉色半固体。加入40mL去离子水洗涤上述淡粉色半固体,然后用(20mL*3)乙酸乙酯萃取,合并有机层并用无水MgSO4干燥,浓缩,得黄白色固体1.16g,收率88%,HPLC纯度为99%。1.14 g (6 mmol) of p-toluenesulfonyl chloride and 10 mL of 1,2-dichloroethane were added to the dry reaction flask, stirred and dissolved at room temperature, and 10 mL of 0.54 g (5 mmol) of 2-aminomethylpyridine and 0.76 g of 2-aminomethylpyridine and 0.76 g (7.5 mmol) triethylamine solution in 1,2-dichloroethane was added dropwise, and the reaction was stirred at room temperature for 6 hours. After the reaction was completed, the reaction solution was concentrated by rotary evaporation to obtain a pale pink semi-solid. 40 mL of deionized water was added to wash the above pale pink semi-solid, then extracted with (20 mL*3) ethyl acetate, the organic layers were combined and dried over anhydrous MgSO 4 , and concentrated to obtain 1.16 g of a yellow-white solid, yield 88%, HPLC purity is 99%.

实施例3Example 3

在干燥的反应瓶中加入1.14g(6mmol)对甲苯磺酰氯及10mL四氢呋喃,室温下搅拌溶解,缓慢滴加10mL含0.54g(5mmol)2-氨甲基吡啶和0.76g(7.5mmol)三乙胺的四氢呋喃,滴加完毕,室温下搅拌反应6小时。反应完毕,将反应液旋蒸浓缩,得到淡粉色半固体。加入40mL去离子水洗涤上述淡粉色半固体,然后用(20mL*3)乙酸乙酯萃取,合并有机层并用无水MgSO4干燥,浓缩,得黄白色固体1.09g,收率83%,HPLC纯度为99%。1.14g (6mmol) of p-toluenesulfonyl chloride and 10mL of tetrahydrofuran were added to the dry reaction flask, stirred and dissolved at room temperature, and 10mL of 0.54g (5mmol) of 2-aminomethylpyridine and 0.76g (7.5mmol) of triethyl were slowly added dropwise. The amine in tetrahydrofuran was added dropwise, and the reaction was stirred at room temperature for 6 hours. After the reaction was completed, the reaction solution was concentrated by rotary evaporation to obtain a pale pink semi-solid. 40 mL of deionized water was added to wash the above pale pink semi-solid, then extracted with (20 mL*3) ethyl acetate, the organic layers were combined and dried over anhydrous MgSO 4 , and concentrated to obtain 1.09 g of a yellow-white solid, yield 83%, HPLC purity is 99%.

实施例4Example 4

在干燥的反应瓶中加入1.14g(6mmol)对甲苯磺酰氯及10mL二氯甲烷,室温下搅拌溶解,缓慢滴加10mL含0.54g(5mmol)2-氨甲基吡啶和0.44g(7.5mmol)三甲胺的二氯甲烷溶液,滴加完毕,室温下搅拌反应6小时。反应完毕,将反应液旋蒸浓缩,得到淡粉色固体。在冰水浴中,用去离子水充分洗涤上述淡粉色固体,过滤,烘干,得黄白色粉末1.18g,收率90%,HPLC纯度为99%。1.14g (6mmol) of p-toluenesulfonyl chloride and 10mL of dichloromethane were added to the dry reaction flask, stirred and dissolved at room temperature, and 10mL of 0.54g (5mmol) of 2-aminomethylpyridine and 0.44g (7.5mmol) of 0.54g (5mmol) of 2-aminomethylpyridine and 0.44g (7.5mmol) were slowly added dropwise The solution of trimethylamine in dichloromethane was added dropwise, and the reaction was stirred at room temperature for 6 hours. After the reaction was completed, the reaction solution was concentrated by rotary evaporation to obtain a pale pink solid. In an ice-water bath, the above pale pink solid was fully washed with deionized water, filtered and dried to obtain 1.18 g of a yellow-white powder with a yield of 90% and a HPLC purity of 99%.

实施例5Example 5

在干燥的反应瓶中加入1.14g(6mmol)对甲苯磺酰氯及10mL二氯甲烷,室温下搅拌溶解,缓慢滴加10mL含0.54g(5mmol)2-氨甲基吡啶和0.59g(7.5mmol)吡啶的二氯甲烷溶液,滴加完毕,室温下搅拌反应6小时。反应完毕,将反应液旋蒸浓缩,得到淡粉色固体。在冰水浴中,用去离子水充分洗涤上述淡粉色固体,过滤,烘干,得黄白色粉末1.13g,收率86%,HPLC纯度为99%。1.14g (6mmol) of p-toluenesulfonyl chloride and 10mL of dichloromethane were added to the dry reaction flask, stirred and dissolved at room temperature, and 10mL of 0.54g (5mmol) of 2-aminomethylpyridine and 0.59g (7.5mmol) of 0.54g (5mmol) of 2-aminomethylpyridine and 0.59g (7.5mmol) were slowly added dropwise. The solution of pyridine in dichloromethane was added dropwise, and the reaction was stirred at room temperature for 6 hours. After the reaction was completed, the reaction solution was concentrated by rotary evaporation to obtain a pale pink solid. In an ice-water bath, the above pale pink solid was fully washed with deionized water, filtered and dried to obtain 1.13 g of a yellow-white powder with a yield of 86% and a HPLC purity of 99%.

实施例6Example 6

在干燥的反应瓶中加入1.14g(6mmol)对甲苯磺酰氯及10mL二氯甲烷,室温下搅拌溶解,缓慢滴加10mL含0.54g(5mmol)2-氨甲基吡啶和0.63g(7.5mmol)哌啶的二氯甲烷溶液,滴加完毕,室温下搅拌反应6小时。反应完毕,将反应液旋蒸浓缩,得到淡粉色固体。在冰水浴中,用去离子水充分洗涤上述淡粉色固体,过滤,烘干,得黄白色粉末1.19g,收率91%,HPLC纯度为99%。1.14g (6mmol) of p-toluenesulfonyl chloride and 10mL of dichloromethane were added to the dry reaction flask, stirred and dissolved at room temperature, and 10mL containing 0.54g (5mmol) of 2-aminomethylpyridine and 0.63g (7.5mmol) of 0.54g (5mmol) was slowly added dropwise. The solution of piperidine in dichloromethane was added dropwise, and the reaction was stirred at room temperature for 6 hours. After the reaction was completed, the reaction solution was concentrated by rotary evaporation to obtain a pale pink solid. In an ice-water bath, the above pale pink solid was fully washed with deionized water, filtered and dried to obtain 1.19 g of a yellow-white powder with a yield of 91% and a HPLC purity of 99%.

实施例7Example 7

取一干燥的三口烧瓶,加入按照实施例1的方法制备得到的中间产品即N-(2-吡啶甲基)对甲苯磺酰胺0.65g(2.5mmol),异丙醇7.5mL,DMF-DMA 7.5mL,一水合醋酸铜25mg(0.125mmol),之后升温至80℃反应8小时。反应结束,冷却至室温,加入30mL去离子水洗涤,然后用(20mL*3)乙酸乙酯萃取,合并有机层并用无水MgSO4干燥,浓缩得到黄色液体,经柱层析分离得到白色粉末0.24g,收率42%,HPLC纯度为99%。Take a dry three-necked flask, add the intermediate product prepared according to the method of Example 1, namely N-(2-pyridylmethyl) p-toluenesulfonamide 0.65g (2.5mmol), isopropanol 7.5mL, DMF-DMA 7.5g mL, 25 mg (0.125 mmol) of copper acetate monohydrate, and then the temperature was raised to 80° C. to react for 8 hours. The reaction was completed, cooled to room temperature, washed with 30 mL of deionized water, then extracted with (20 mL*3) ethyl acetate, the organic layers were combined and dried with anhydrous MgSO 4 , concentrated to obtain a yellow liquid, which was separated by column chromatography to obtain a white powder 0.24 g, yield 42%, HPLC purity 99%.

实施例8Example 8

取一干燥的三口烧瓶,加入按照实施例1的方法制备得到的中间产品即N-(2-吡啶甲基)对甲苯磺酰胺0.65g(2.5mmol),正丙醇7.5mL,DMF-DMA 7.5mL,一水合醋酸铜25mg(0.125mmol),之后升温至80℃反应8小时。反应结束,冷却至室温,加入30mL去离子水洗涤,然后用(20mL*3)乙酸乙酯萃取,合并有机层并用无水MgSO4干燥,浓缩得到黄色液体,经柱层析分离得到白色粉末0.32g,收率57%,HPLC纯度为99%。Take a dry three-necked flask, add the intermediate product prepared according to the method in Example 1, namely N-(2-pyridylmethyl) p-toluenesulfonamide 0.65g (2.5mmol), n-propanol 7.5mL, DMF-DMA 7.5g mL, 25 mg (0.125 mmol) of copper acetate monohydrate, and then the temperature was raised to 80° C. to react for 8 hours. The reaction was completed, cooled to room temperature, washed with 30 mL of deionized water, then extracted with (20 mL*3) ethyl acetate, the organic layers were combined and dried with anhydrous MgSO 4 , concentrated to obtain a yellow liquid, which was separated by column chromatography to obtain a white powder 0.32 g, yield 57%, HPLC purity 99%.

实施例9Example 9

取一干燥的三口烧瓶,加入按照实施例1的方法制备得到的中间产品即N-(2-吡啶甲基)对甲苯磺酰胺0.65g(2.5mmol),正丁醇7.5mL,DMF-DMA 7.5mL,一水合醋酸铜25mg(0.125mmol),之后升温至80℃反应8小时。反应结束,冷却至室温,加入30mL去离子水洗涤,然后用(20mL*3)乙酸乙酯萃取,合并有机层并用无水MgSO4干燥,浓缩得到黄色液体,经柱层析分离得到白色粉末0.29g,收率51%,HPLC纯度为99%。Take a dry three-necked flask, add the intermediate product prepared according to the method of Example 1, namely N-(2-pyridylmethyl) p-toluenesulfonamide 0.65g (2.5mmol), n-butanol 7.5mL, DMF-DMA 7.5 mL, 25 mg (0.125 mmol) of copper acetate monohydrate, and then the temperature was raised to 80° C. to react for 8 hours. The reaction was completed, cooled to room temperature, washed with 30 mL of deionized water, then extracted with (20 mL*3) ethyl acetate, the organic layers were combined and dried over anhydrous MgSO 4 , concentrated to obtain a yellow liquid, which was separated by column chromatography to obtain a white powder 0.29 g, yield 51%, HPLC purity 99%.

实施例10Example 10

取一干燥的三口烧瓶,加入按照实施例1的方法制备得到的中间产品即N-(2-吡啶甲基)对甲苯磺酰胺0.65g(2.5mmol),二乙二醇7.5mL,DMF-DMA 7.5mL,一水合醋酸铜25mg(0.125mmol),之后升温至80℃反应8小时。反应结束,冷却至室温,加入30mL去离子水洗涤,然后用(20mL*3)乙酸乙酯萃取,合并有机层并用无水MgSO4干燥,浓缩得到黄色液体,经柱层析分离得到白色粉末0.41g,收率73%,HPLC纯度为99%。Take a dry three-necked flask, add the intermediate product prepared according to the method of Example 1, namely N-(2-pyridylmethyl) p-toluenesulfonamide 0.65g (2.5mmol), diethylene glycol 7.5mL, DMF-DMA 7.5 mL, 25 mg (0.125 mmol) of copper acetate monohydrate, and then the temperature was raised to 80° C. to react for 8 hours. The reaction was completed, cooled to room temperature, washed with 30 mL of deionized water, then extracted with (20 mL*3) ethyl acetate, the organic layers were combined and dried with anhydrous MgSO 4 , concentrated to obtain a yellow liquid, which was separated by column chromatography to obtain a white powder 0.41 g, 73% yield, 99% HPLC purity.

实施例11Example 11

取一干燥的三口烧瓶,加入按照实施例1的方法制备得到的中间产品即N-(2-吡啶甲基)对甲苯磺酰胺0.65g(2.5mmol),乙二醇7.5mL,DMF-DMA 7.5mL,氯化亚铜12mg(0.125mmol),之后升温至80℃反应8小时。反应结束,冷却至室温,加入30mL去离子水洗涤,然后用(20mL*3)乙酸乙酯萃取,合并有机层并用无水MgSO4干燥,浓缩得到黄色液体,经柱层析分离得到白色粉末0.47g,收率84%,HPLC纯度为99%。Take a dry three-necked flask, add the intermediate product prepared according to the method of Example 1, namely N-(2-pyridylmethyl) p-toluenesulfonamide 0.65g (2.5mmol), ethylene glycol 7.5mL, DMF-DMA 7.5 mL, 12 mg (0.125 mmol) of cuprous chloride, and then the temperature was raised to 80° C. to react for 8 hours. The reaction was completed, cooled to room temperature, washed with 30 mL of deionized water, then extracted with (20 mL*3) ethyl acetate, the organic layers were combined and dried with anhydrous MgSO 4 , concentrated to obtain a yellow liquid, which was separated by column chromatography to obtain a white powder 0.47 g g, 84% yield, 99% HPLC purity.

实施例12Example 12

取一干燥的三口烧瓶,加入按照实施例1的方法制备得到的中间产品即N-(2-吡啶甲基)对甲苯磺酰胺0.65g(2.5mmol),乙二醇7.5mL,DMF-DMA 7.5mL,氯化铜19mg(0.125mmol),之后升温至80℃反应8小时。反应结束,冷却至室温,加入30mL去离子水洗涤,然后用(20mL*3)乙酸乙酯萃取,合并有机层并用无水MgSO4干燥,浓缩得到黄色液体,经柱层析分离得到白色粉末0.43g,收率77%,HPLC纯度为99%。Take a dry three-necked flask, add the intermediate product prepared according to the method of Example 1, namely N-(2-pyridylmethyl) p-toluenesulfonamide 0.65g (2.5mmol), ethylene glycol 7.5mL, DMF-DMA 7.5 mL, 19 mg (0.125 mmol) of copper chloride, and then the temperature was raised to 80° C. to react for 8 hours. The reaction was completed, cooled to room temperature, washed with 30 mL of deionized water, then extracted with (20 mL*3) ethyl acetate, the organic layers were combined and dried with anhydrous MgSO 4 , concentrated to obtain a yellow liquid, which was separated by column chromatography to obtain a white powder 0.43 g, 77% yield, 99% HPLC purity.

实施例13Example 13

取一干燥的三口烧瓶,加入按照实施例1的方法制备得到的中间产品即N-(2-吡啶甲基)对甲苯磺酰胺0.65g(2.5mmol),乙二醇7.5mL,DMF-DMA 7.5mL,硝酸铜23mg(0.125mmol),之后升温至80℃反应8小时。反应结束,冷却至室温,加入30mL去离子水洗涤,然后用(20mL*3)乙酸乙酯萃取,合并有机层并用无水MgSO4干燥,浓缩得到黄色液体,经柱层析分离得到白色粉末0.46g,收率82%,HPLC纯度为99%。Take a dry three-necked flask, add the intermediate product prepared according to the method of Example 1, namely N-(2-pyridylmethyl) p-toluenesulfonamide 0.65g (2.5mmol), ethylene glycol 7.5mL, DMF-DMA 7.5 mL, 23 mg (0.125 mmol) of copper nitrate, and then the temperature was raised to 80° C. to react for 8 hours. The reaction was completed, cooled to room temperature, washed with 30 mL of deionized water, then extracted with (20 mL*3) ethyl acetate, the organic layers were combined and dried with anhydrous MgSO 4 , concentrated to obtain a yellow liquid, which was separated by column chromatography to obtain a white powder 0.46 g, 82% yield, 99% HPLC purity.

实施例14Example 14

取一干燥的三口烧瓶,加入按照实施例1的方法制备得到的中间产品即N-(2-吡啶甲基)对甲苯磺酰胺0.65g(2.5mmol),乙二醇7.5mL,DMF-DMA 7.5mL,溴化铜28mg(0.125mmol),之后升温至80℃反应8小时。反应结束,冷却至室温,加入30mL去离子水洗涤,然后用(20mL*3)乙酸乙酯萃取,合并有机层并用无水MgSO4干燥,浓缩得到黄色液体,经柱层析分离得到白色粉末0.40g,收率71%,HPLC纯度为99%。Take a dry three-necked flask, add the intermediate product prepared according to the method of Example 1, namely N-(2-pyridylmethyl) p-toluenesulfonamide 0.65g (2.5mmol), ethylene glycol 7.5mL, DMF-DMA 7.5 mL, 28 mg (0.125 mmol) of copper bromide, and then the temperature was raised to 80° C. to react for 8 hours. The reaction was completed, cooled to room temperature, washed with 30 mL of deionized water, then extracted with (20 mL*3) ethyl acetate, the organic layers were combined and dried with anhydrous MgSO 4 , concentrated to obtain a yellow liquid, which was separated by column chromatography to obtain a white powder 0.40 g, 71% yield, 99% HPLC purity.

实施例15Example 15

取一干燥的三口烧瓶,加入按照实施例1的方法制备得到的中间产品即N-(2-吡啶甲基)对甲苯磺酰胺0.65g(2.5mmol),乙二醇7.5mL,DMF-DMA 7.5mL,溴化亚铜18mg(0.125mmol),之后升温至80℃反应8小时。反应结束,冷却至室温,加入30mL去离子水洗涤,然后用(20mL*3)乙酸乙酯萃取,合并有机层并用无水MgSO4干燥,浓缩得到黄色液体,经柱层析分离得到白色粉末0.41g,收率73%,HPLC纯度为99%。Take a dry three-necked flask, add the intermediate product prepared according to the method of Example 1, namely N-(2-pyridylmethyl) p-toluenesulfonamide 0.65g (2.5mmol), ethylene glycol 7.5mL, DMF-DMA 7.5 mL, 18 mg (0.125 mmol) of cuprous bromide, and then the temperature was raised to 80° C. to react for 8 hours. The reaction was completed, cooled to room temperature, washed with 30 mL of deionized water, then extracted with (20 mL*3) ethyl acetate, the organic layers were combined and dried with anhydrous MgSO 4 , concentrated to obtain a yellow liquid, which was separated by column chromatography to obtain a white powder 0.41 g, 73% yield, 99% HPLC purity.

实施例16Example 16

在干燥的反应瓶中加入1.40g(6mmol)对叔丁基苯磺酰氯及10mL二氯甲烷,室温下搅拌溶解,缓慢滴加10mL含0.54g(5mmol)2-氨甲基吡啶和0.76g(7.5mmol)三乙胺的二氯甲烷溶液,滴加完毕,室温下搅拌反应6小时。反应完毕,将反应液旋蒸浓缩,得到糊状物。在冰水浴中,用去离子水充分洗涤上述糊状物,其凝固成固体,过滤,烘干,得白色粉末1.43g,收率94%,HPLC纯度为99%。1.40g (6mmol) of p-tert-butylbenzenesulfonyl chloride and 10mL of dichloromethane were added to the dry reaction flask, stirred and dissolved at room temperature, and 10mL of 0.54g (5mmol) of 2-aminomethylpyridine and 0.76g ( 7.5 mmol) triethylamine solution in dichloromethane was added dropwise, and the reaction was stirred at room temperature for 6 hours. After the completion of the reaction, the reaction solution was concentrated by rotary evaporation to obtain a paste. In an ice-water bath, the above paste was fully washed with deionized water, solidified into a solid, filtered and dried to obtain 1.43 g of white powder with a yield of 94% and a HPLC purity of 99%.

取一干燥的三口烧瓶,加入上述中间产品即N-(2-吡啶甲基)对叔丁基苯磺酰胺0.76g(2.5mmol),乙二醇7.5mL,DMF-DMA 7.5mL,一水合醋酸铜25mg(0.125mmol),之后升温至80℃反应8小时。反应结束,冷却至室温,加入30mL去离子水洗涤,然后用(20mL*3)乙酸乙酯萃取,合并有机层并用无水MgSO4干燥,浓缩得到黄色液体,经柱层析分离得到白色粉末0.60g,收率89%,HPLC纯度为99%。核磁数据见图2。Get a dry three-necked flask, add above-mentioned intermediate product namely N-(2-pyridylmethyl) p-tert-butylbenzenesulfonamide 0.76g (2.5mmol), ethylene glycol 7.5mL, DMF-DMA 7.5mL, acetic acid monohydrate After 25 mg (0.125 mmol) of copper, the temperature was raised to 80° C. and reacted for 8 hours. The reaction was completed, cooled to room temperature, washed with 30 mL of deionized water, then extracted with (20 mL*3) ethyl acetate, the organic layers were combined and dried with anhydrous MgSO 4 , concentrated to obtain a yellow liquid, which was separated by column chromatography to obtain a white powder 0.60 g, yield 89%, HPLC purity 99%. The NMR data are shown in Figure 2.

实施例17Example 17

在干燥的反应瓶中加入1.24g(6mmol)对甲氧基苯磺酰氯及10mL二氯甲烷,室温下搅拌溶解,缓慢滴加10mL含0.54g(5mmol)2-氨甲基吡啶和0.76g(7.5mmol)三乙胺的二氯甲烷溶液,滴加完毕,室温下搅拌反应6小时。反应完毕,将反应液旋蒸浓缩,得到糊状物。在冰水浴中,用去离子水充分洗涤上述糊状物,其凝固成固体,过滤,烘干,得黄白色粉末1.26g,收率91%,HPLC纯度为99%。1.24g (6mmol) of p-methoxybenzenesulfonyl chloride and 10mL of dichloromethane were added to the dry reaction flask, stirred and dissolved at room temperature, and 10mL of 0.54g (5mmol) of 2-aminomethylpyridine and 0.76g ( 7.5 mmol) triethylamine solution in dichloromethane was added dropwise, and the reaction was stirred at room temperature for 6 hours. After the completion of the reaction, the reaction solution was concentrated by rotary evaporation to obtain a paste. In an ice-water bath, the paste was fully washed with deionized water, solidified into a solid, filtered and dried to obtain 1.26 g of a yellow-white powder with a yield of 91% and a HPLC purity of 99%.

取一干燥的三口烧瓶,加入上述中间产品即N-(2-吡啶甲基)对甲氧基苯磺酰胺0.70g(2.5mmol),乙二醇7.5mL,DMF-DMA7.5mL,一水合醋酸铜25mg(0.125mmol),之后升温至80℃反应8小时。反应结束,冷却至室温,加入30mL去离子水洗涤,然后用(20mL*3)乙酸乙酯萃取,合并有机层并用无水MgSO4干燥,浓缩得到黄色液体,经柱层析分离得到白色粉末0.52g,收率86%,HPLC纯度为99%。核磁数据见图3。Take a dry three-necked flask, add the above-mentioned intermediate product, namely N-(2-pyridylmethyl) p-methoxybenzenesulfonamide 0.70g (2.5mmol), ethylene glycol 7.5mL, DMF-DMA 7.5mL, acetic acid monohydrate After 25 mg (0.125 mmol) of copper, the temperature was raised to 80° C. and reacted for 8 hours. The reaction was completed, cooled to room temperature, washed with 30 mL of deionized water, then extracted with (20 mL*3) ethyl acetate, the organic layers were combined and dried with anhydrous MgSO 4 , concentrated to obtain a yellow liquid, which was separated by column chromatography to obtain a white powder 0.52 g, yield 86%, HPLC purity 99%. The NMR data are shown in Figure 3.

实施例18Example 18

在干燥的反应瓶中加入1.06g(6mmol)苯磺酰氯及10mL二氯甲烷,室温下搅拌溶解,缓慢滴加10mL含0.54g(5mmol)2-氨甲基吡啶和0.76g(7.5mmol)三乙胺的二氯甲烷溶液,滴加完毕,室温下搅拌反应6小时。反应完毕,将反应液旋蒸浓缩,得到糊状物。在冰水浴中,用去离子水充分洗涤上述糊状物,其凝固成固体,过滤,烘干,得白色粉末1.05g,收率85%,,HPLC纯度为99%。Add 1.06g (6mmol) of benzenesulfonyl chloride and 10mL of dichloromethane to the dry reaction flask, stir and dissolve at room temperature, and slowly dropwise add 10mL containing 0.54g (5mmol) of 2-aminomethylpyridine and 0.76g (7.5mmol) of trichloromethane. The dichloromethane solution of ethylamine was added dropwise, and the reaction was stirred at room temperature for 6 hours. After the completion of the reaction, the reaction solution was concentrated by rotary evaporation to obtain a paste. In an ice-water bath, the above paste was fully washed with deionized water, solidified into a solid, filtered and dried to obtain 1.05 g of white powder with a yield of 85% and HPLC purity of 99%.

取一干燥的三口烧瓶,加入上述中间产品即N-(2-吡啶甲基)苯磺酰胺0.62g(2.5mmol),乙二醇7.5mL,DMF-DMA 7.5mL,一水合醋酸铜25mg(0.125mmol),之后升温至80℃反应8小时。反应结束,冷却至室温,加入30mL去离子水洗涤,然后用(20mL*3)乙酸乙酯萃取,合并有机层并用无水MgSO4干燥,浓缩得到黄色液体,经柱层析分离得到白色粉末0.36g,收率67%,HPLC纯度为99%。核磁数据见图4。Get a dry three-necked flask, add above-mentioned intermediate product namely N-(2-pyridylmethyl) benzenesulfonamide 0.62g (2.5mmol), ethylene glycol 7.5mL, DMF-DMA 7.5mL, copper acetate monohydrate 25mg (0.125g) mmol), and then the temperature was raised to 80°C for 8 hours. The reaction was completed, cooled to room temperature, washed with 30 mL of deionized water, then extracted with (20 mL*3) ethyl acetate, the organic layers were combined and dried with anhydrous MgSO 4 , concentrated to obtain a yellow liquid, which was separated by column chromatography to obtain a white powder 0.36 g, yield 67%, HPLC purity 99%. The NMR data are shown in Figure 4.

实施例19Example 19

在干燥的反应瓶中加入1.53g(6mmol)对溴基苯磺酰氯及10mL二氯甲烷,室温下搅拌溶解,缓慢滴加10mL含0.54g(5mmol)2-氨甲基吡啶和0.76g(7.5mmol)三乙胺的二氯甲烷溶液,滴加完毕,室温下搅拌反应6小时。反应完毕,将反应液旋蒸浓缩,得到糊状物。在冰水浴中,用去离子水充分洗涤上述糊状物,其凝固成固体,过滤,烘干,得白色粉末1.47g,收率90%,HPLC纯度为99%。1.53g (6mmol) of p-bromobenzenesulfonyl chloride and 10mL of dichloromethane were added to the dry reaction flask, stirred and dissolved at room temperature, and 10mL of 0.54g (5mmol) of 2-aminomethylpyridine and 0.76g (7.5g of 2-aminomethylpyridine) were slowly added dropwise. mmol) triethylamine in dichloromethane, the dropwise addition was completed, and the reaction was stirred at room temperature for 6 hours. After the reaction was completed, the reaction solution was concentrated by rotary evaporation to obtain a paste. In an ice-water bath, the above paste was fully washed with deionized water, solidified into a solid, filtered and dried to obtain 1.47 g of white powder with a yield of 90% and a HPLC purity of 99%.

取一干燥的三口烧瓶,加入上述中间产品即N-(2-吡啶甲基)对溴基苯磺酰胺0.82g(2.5mmol),乙二醇7.5mL,DMF-DMA7.5mL,一水合醋酸铜25mg(0.125mmol),之后升温至80℃反应8小时。反应结束,冷却至室温,加入30mL去离子水洗涤,然后用(20mL*3)乙酸乙酯萃取,合并有机层并用无水MgSO4干燥,浓缩得到黄色液体,经柱层析分离得到白色粉末0.68g,收率93%,HPLC纯度为99%。核磁数据见图5。Take a dry three-necked flask, add the above-mentioned intermediate product, namely N-(2-pyridylmethyl) p-bromobenzenesulfonamide 0.82g (2.5mmol), ethylene glycol 7.5mL, DMF-DMA 7.5mL, copper acetate monohydrate 25 mg (0.125 mmol), and then the temperature was raised to 80° C. to react for 8 hours. The reaction was completed, cooled to room temperature, washed with 30 mL of deionized water, then extracted with (20 mL*3) ethyl acetate, the organic layers were combined and dried with anhydrous MgSO 4 , concentrated to obtain a yellow liquid, which was separated by column chromatography to obtain a white powder 0.68 g, 93% yield, 99% HPLC purity. The NMR data are shown in Figure 5.

实施例20Example 20

在干燥的反应瓶中加入1.31g(6mmol)均三甲基苯磺酰氯及10mL二氯甲烷,室温下搅拌溶解,缓慢滴加10mL含0.54g(5mmol)2-氨甲基吡啶和0.76g(7.5mmol)三乙胺的二氯甲烷溶液,滴加完毕,室温下搅拌反应6小时。反应完毕,将反应液旋蒸浓缩,得到糊状物。在冰水浴中,用去离子水充分洗涤上述糊状物,其凝固成固体,过滤,烘干,得黄白色粉末1.35g,收率93%,HPLC纯度为99%。1.31 g (6 mmol) of mesitylene sulfonyl chloride and 10 mL of dichloromethane were added to the dry reaction flask, stirred and dissolved at room temperature, and 10 mL of 0.54 g (5 mmol) of 2-aminomethylpyridine and 0.76 g ( 7.5 mmol) triethylamine solution in dichloromethane was added dropwise, and the reaction was stirred at room temperature for 6 hours. After the completion of the reaction, the reaction solution was concentrated by rotary evaporation to obtain a paste. In an ice-water bath, the paste was fully washed with deionized water, solidified into a solid, filtered and dried to obtain 1.35 g of a yellow-white powder with a yield of 93% and HPLC purity of 99%.

取一干燥的三口烧瓶,加入上述中间产品即N-(2-吡啶甲基)均三甲基苯磺酰胺0.73g(2.5mmol),乙二醇7.5mL,DMF-DMA 7.5mL,一水合醋酸铜25mg(0.125mmol),之后升温至80℃反应8小时。反应结束,冷却至室温,加入30mL去离子水洗涤,然后用(20mL*3)乙酸乙酯萃取,合并有机层并用无水MgSO4干燥,浓缩得到棕黄色液体,经柱层析分离得到白色粉末0.60g,收率94%,HPLC纯度为99%。核磁数据见图6、图7。Get a dry three-necked flask, add above-mentioned intermediate product namely N-(2-pyridylmethyl) mesitylene sulfonamide 0.73g (2.5mmol), ethylene glycol 7.5mL, DMF-DMA 7.5mL, acetic acid monohydrate After 25 mg (0.125 mmol) of copper, the temperature was raised to 80° C. and reacted for 8 hours. The reaction was completed, cooled to room temperature, washed with 30 mL of deionized water, and then extracted with (20 mL*3) ethyl acetate. The organic layers were combined and dried with anhydrous MgSO 4 . Concentrated to obtain a brownish-yellow liquid, which was separated by column chromatography to obtain a white powder 0.60 g, yield 94%, HPLC purity 99%. The NMR data are shown in Figure 6 and Figure 7.

实施例1、7~15所得目标产品经核磁数据、熔点数据检测,与已报道文献中对甲苯磺酰脒基本一致。The target products obtained in Examples 1 and 7-15 are basically consistent with the p-toluenesulfonyl amidine in the reported literature through the detection of nuclear magnetic data and melting point data.

熔点:134.6℃-135.0℃。Melting point: 134.6℃-135.0℃.

实施例16所得目标产品经核磁数据、熔点数据检测,与已报道文献中对叔丁基苯磺酰脒基本一致。The target product obtained in Example 16 is basically consistent with the p-tert-butylbenzenesulfonyl amidine in the reported literature through the detection of nuclear magnetic data and melting point data.

熔点:161.2℃-162.1℃。Melting point: 161.2℃-162.1℃.

实施例17所得目标产品经核磁数据、熔点数据检测,与已报道文献中对甲氧基苯磺酰脒基本一致。The target product obtained in Example 17 is basically consistent with the p-methoxybenzenesulfonyl amidine in the reported literature through the detection of nuclear magnetic data and melting point data.

熔点:152.2℃-153.7℃。Melting point: 152.2℃-153.7℃.

实施例18所得目标产品经核磁数据、熔点数据检测,与已报道文献中苯磺酰脒基本一致。The target product obtained in Example 18 was detected by nuclear magnetic data and melting point data, which was basically consistent with the benzenesulfonyl amidine in the reported literature.

熔点:129.1℃-131.1℃。Melting point: 129.1℃-131.1℃.

实施例19所得目标产品经核磁数据、熔点数据检测,与已报道文献中对溴基苯磺酰脒基本一致。The target product obtained in Example 19 was detected by nuclear magnetic data and melting point data, which was basically consistent with the p-bromobenzenesulfonyl amidine in the reported literature.

熔点:142.5℃-143.0℃。Melting point: 142.5℃-143.0℃.

实施例20所得目标产品经核磁数据、熔点数据检测可判定为均三甲基苯磺酰脒。The target product obtained in Example 20 can be determined to be mesitylenesulfonyl amidine through the detection of nuclear magnetic data and melting point data.

熔点:159.4℃-159.9℃。Melting point: 159.4℃-159.9℃.

Claims (10)

1.一种2-氨甲基吡啶与DMF-DMA作为胺源的磺酰脒的制备方法,其特征在于,包括:磺酰氯与2-氨甲基吡啶在有机碱存在下,反应得到的中间体再与DMF-DMA催化剂存在下反应得到磺酰脒;1. a preparation method of 2-aminomethylpyridine and DMF-DMA as the sulfonyl amidine of amine source, is characterized in that, comprises: sulfonyl chloride and 2-aminomethylpyridine are in the presence of organic base, and the middle that reaction obtains The product is then reacted with DMF-DMA catalyst to obtain sulfonyl amidine; 所述磺酰氯、中间体以及磺酰脒的结构分别如下式所示:The structures of the sulfonyl chloride, the intermediate and the sulfonyl amidine are respectively shown in the following formulas:
Figure FDA0002528121000000011
Figure FDA0002528121000000011
R1选自C1-C5的烷基;C1-C5的烷氧基;卤素原子;氢原子。R 1 is selected from a C1-C5 alkyl group; a C1-C5 alkoxy group; a halogen atom; a hydrogen atom. R2,R3各自独立的选自C1-C5的烷基;氢原子。R 2 and R 3 are each independently selected from C1-C5 alkyl groups; hydrogen atoms.
2.根据权利要求1所述的2-氨甲基吡啶与DMF-DMA作为胺源的磺酰脒的制备方法,其特征在于,包括:2. the preparation method of the sulfonyl amidine of 2-aminomethylpyridine according to claim 1 and DMF-DMA as amine source, is characterized in that, comprises: (1)向反应溶剂I中加入磺酰氯,溶解得到磺酰氯溶液;将2-氨甲基吡啶和有机碱的混合物滴加到上述磺酰氯溶液中,反应完毕,经后处理得中间体;(1) in reaction solvent 1, add sulfonyl chloride, dissolve and obtain sulfonyl chloride solution; The mixture of 2-aminomethylpyridine and organic base is added dropwise in above-mentioned sulfonyl chloride solution, and the reaction is completed, and intermediate is obtained through aftertreatment; (2)将步骤(1)得到的中间体、DMF-DMA、催化剂与反应溶剂II混合,反应完毕,后处理得磺酰脒。(2) mixing the intermediate obtained in step (1), DMF-DMA, catalyst and reaction solvent II, the reaction is completed, and the sulfonyl amidine is obtained after post-processing. 3.根据权利要求1或2所述的2-氨甲基吡啶与DMF-DMA作为胺源的磺酰脒的制备方法,其特征在于,所述磺酰氯为对甲基苯磺酰氯、对甲氧基苯磺酰氯、对叔丁基苯磺酰氯、苯磺酰氯、对溴基苯磺酰氯、均三甲基苯磺酰氯。3. 2-aminomethylpyridine according to claim 1 and 2 and DMF-DMA are as the preparation method of the sulfonyl amidine of amine source, it is characterized in that, described sulfonyl chloride is p-toluenesulfonyl chloride, p-methyl benzene Oxybenzenesulfonyl chloride, p-tert-butylbenzenesulfonyl chloride, benzenesulfonyl chloride, p-bromobenzenesulfonyl chloride, mesitylenesulfonyl chloride. 4.根据权利要求1或2所述的2-氨甲基吡啶与DMF-DMA作为胺源的磺酰脒的制备方法,其特征在于,所述磺酰氯与2-氨甲基吡啶反应的溶剂选自二氯甲烷、1,2-二氯乙烷、四氢呋喃中的一种或多种;所述中间体与DMF-DMA反应的溶剂选自乙二醇、异丙醇、正丙醇、正丁醇、二乙二醇中的一种或多种。4. the preparation method of the sulfonyl amidine of 2-aminomethyl pyridine according to claim 1 and 2 and DMF-DMA as amine source, it is characterized in that, the solvent that described sulfonyl chloride and 2-amino methyl pyridine react One or more selected from dichloromethane, 1,2-dichloroethane and tetrahydrofuran; the solvent for the reaction of the intermediate and DMF-DMA is selected from ethylene glycol, isopropanol, n-propanol, normal One or more of butanol and diethylene glycol. 5.根据权利要求1或2所述的2-氨甲基吡啶与DMF-DMA作为胺源的磺酰脒的制备方法,其特征在于,所述有机碱为三乙胺、三甲胺、吡啶、哌啶中的一种或多种。5. 2-aminomethylpyridine according to claim 1 and 2 and DMF-DMA are used as the preparation method of the sulfonyl amidine of amine source, it is characterized in that, described organic base is triethylamine, trimethylamine, pyridine, One or more of piperidines. 6.根据权利要求1或2所述的2-氨甲基吡啶与DMF-DMA作为胺源的磺酰脒的制备方法,其特征在于,所述2-氨甲基吡啶与磺酰氯、有机碱的摩尔比为1:(1~2):(1~2)。6. 2-aminomethylpyridine according to claim 1 and 2 and DMF-DMA are used as the preparation method of the sulfonyl amidine of amine source, it is characterized in that, described 2-aminomethylpyridine and sulfonyl chloride, organic base The molar ratio is 1:(1~2):(1~2). 7.根据权利要求1或2所述的2-氨甲基吡啶与DMF-DMA作为胺源的磺酰脒的制备方法,其特征在于,所述中间体与催化剂的摩尔比为1:0.02~0.1,所述DMF-DMA与中间体的重量比为5~30:1。7. 2-aminomethylpyridine and DMF-DMA according to claim 1 and 2 are used as the preparation method of the sulfonyl amidine of amine source, it is characterized in that, the mol ratio of described intermediate and catalyzer is 1:0.02~ 0.1, and the weight ratio of the DMF-DMA to the intermediate is 5 to 30:1. 8.根据权利要求1或2所述的2-氨甲基吡啶与DMF-DMA作为胺源的磺酰脒的制备方法,其特征在于,所述催化剂选自一水合醋酸铜、氯化亚铜、氯化铜、硝酸铜、溴化铜、溴化亚铜中的一种或多种。8. 2-aminomethylpyridine according to claim 1 and 2 and DMF-DMA are used as the preparation method of the sulfonyl amidine of amine source, it is characterized in that, described catalyzer is selected from monohydrate copper acetate, cuprous chloride , one or more of cupric chloride, cupric nitrate, cupric bromide and cuprous bromide. 9.根据权利要求1或2所述的2-氨甲基吡啶与DMF-DMA作为胺源的磺酰脒的制备方法,其特征在于,所述磺酰氯与2-氨甲基吡啶反应的温度为20~40℃;所述中间体与DMF-DMA反应的温度为60~100℃。9. 2-aminomethylpyridine according to claim 1 and 2 and DMF-DMA are used as the preparation method of the sulfonyl amidine of amine source, it is characterized in that, the temperature of described sulfonyl chloride and 2-aminomethylpyridine reaction is 20-40°C; the reaction temperature of the intermediate and DMF-DMA is 60-100°C. 10.根据权利要求1或2所述的2-氨甲基吡啶与DMF-DMA作为胺源的磺酰脒的制备方法,其特征在于,所述中间体与DMF-DMA反应的溶剂为乙二醇;所述催化剂为一水合醋酸铜。10. 2-aminomethylpyridine according to claim 1 and 2 and DMF-DMA are used as the preparation method of the sulfonyl amidine of amine source, it is characterized in that, the solvent that described intermediate and DMF-DMA reacts is ethylene glycol alcohol; the catalyst is copper acetate monohydrate.
CN202010510716.1A 2020-06-08 2020-06-08 A kind of preparation method of sulfonyl amidine with 2-aminomethylpyridine and DMF-DMA as amine source Active CN111574413B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010510716.1A CN111574413B (en) 2020-06-08 2020-06-08 A kind of preparation method of sulfonyl amidine with 2-aminomethylpyridine and DMF-DMA as amine source

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010510716.1A CN111574413B (en) 2020-06-08 2020-06-08 A kind of preparation method of sulfonyl amidine with 2-aminomethylpyridine and DMF-DMA as amine source

Publications (2)

Publication Number Publication Date
CN111574413A true CN111574413A (en) 2020-08-25
CN111574413B CN111574413B (en) 2022-04-05

Family

ID=72127359

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010510716.1A Active CN111574413B (en) 2020-06-08 2020-06-08 A kind of preparation method of sulfonyl amidine with 2-aminomethylpyridine and DMF-DMA as amine source

Country Status (1)

Country Link
CN (1) CN111574413B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114940657A (en) * 2022-05-09 2022-08-26 三峡大学 Amidine compound synthesized from N, N, N ', N' -tetramethylethylenediamine

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101039919A (en) * 2004-10-13 2007-09-19 惠氏公司 N-benzenesulfonyl substituted anilino-pyrimidine analogs
CN101213187A (en) * 2005-06-28 2008-07-02 塞诺菲-安万特股份有限公司 Isoquinoline derivatives as inhibitors of RHO-kinase
CN101611012A (en) * 2006-12-27 2009-12-23 塞诺菲-安万特股份有限公司 The isoquinilone derivatives that Cycloalkyl amine replaces
CN104016904A (en) * 2014-06-04 2014-09-03 常州大学 Multi-substituted amidine compound as well as preparation method and application thereof
WO2018085170A1 (en) * 2016-11-01 2018-05-11 Merck Sharp & Dohme Corp. Substituted 6-membered aryl or heteroaryl allosteric modulators of nicotinic acetylcholine receptors
WO2018109649A1 (en) * 2016-12-15 2018-06-21 Glaxosmithkline Intellectual Property Development Limited Ether linked triazoles as nrf2 regulators
CN109516987A (en) * 2018-12-26 2019-03-26 江西富祥药业股份有限公司 A kind of AVM hereinafter Batan centre preparation

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101039919A (en) * 2004-10-13 2007-09-19 惠氏公司 N-benzenesulfonyl substituted anilino-pyrimidine analogs
CN101213187A (en) * 2005-06-28 2008-07-02 塞诺菲-安万特股份有限公司 Isoquinoline derivatives as inhibitors of RHO-kinase
CN101611012A (en) * 2006-12-27 2009-12-23 塞诺菲-安万特股份有限公司 The isoquinilone derivatives that Cycloalkyl amine replaces
CN104016904A (en) * 2014-06-04 2014-09-03 常州大学 Multi-substituted amidine compound as well as preparation method and application thereof
WO2018085170A1 (en) * 2016-11-01 2018-05-11 Merck Sharp & Dohme Corp. Substituted 6-membered aryl or heteroaryl allosteric modulators of nicotinic acetylcholine receptors
WO2018109649A1 (en) * 2016-12-15 2018-06-21 Glaxosmithkline Intellectual Property Development Limited Ether linked triazoles as nrf2 regulators
CN109516987A (en) * 2018-12-26 2019-03-26 江西富祥药业股份有限公司 A kind of AVM hereinafter Batan centre preparation

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
BI, WEN-ZHU ET AL: "Air-Induced One-Pot Synthesis of N-Sulfonylformamidines from Sulfonyl Chlorides, NaN3,and Tertiary/Secondary Amines", 《EUROPEAN JOURNAL OF ORGANIC CHEMISTRY》 *
HUANG, ZHI-YOU ET AL: "An efficient one-pot access to N-(pyridin-2-ylmethyl) substituent biphenyl-4-sulfonamides through water-promoted, palladium-catalyzed,microwave-assisted reactions", 《RSC ADVANCES》 *
JEONG, YURI ET AL: "A Novel Synthesis of N-Sulfonylformamidines from N-Sulfonylsulfonamides", 《SYNTHESIS》 *
KHODAIRY, A. ET AL: "4-Toluenesulfonamide as a Building Block for Synthesis of Novel Triazepines, Pyrimidines, and Azoles", 《JOURNAL OF HETEROCYCLIC CHEMISTRY》 *
LUECKING, ULRICH ET AL: "Macrocyclic aminopyrimidines as multitarget CDK and VEGF-R inhibitors with potent antiproliferative activities", 《CHEMMEDCHEM》 *
伍悦瑄等: "N-氨基磺酰基甲脒类化合物的合成研究", 《化学试剂》 *
张娟等: "酰胺缩醛法合成N,N,N"-三取代甲脒的研究", 《化学通报》 *
张磊等: "N-氨基酰基甲脒类化合物的合成研究", 《化学与生物工程》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114940657A (en) * 2022-05-09 2022-08-26 三峡大学 Amidine compound synthesized from N, N, N ', N' -tetramethylethylenediamine
CN114940657B (en) * 2022-05-09 2023-10-27 三峡大学 Amidine compound synthesized from N, N, N ', N' -tetramethyl ethylenediamine

Also Published As

Publication number Publication date
CN111574413B (en) 2022-04-05

Similar Documents

Publication Publication Date Title
CN114409515B (en) A kind of preparation method of gem-difluoroalkene compound
CN111925356B (en) Synthesis method and application of chiral quinoline-imidazoline ligand
CN111039737B (en) A kind of synthetic method of 2-cyanoalkylsulfonyl 3,4-dihydronaphthalene compound
CN108314658A (en) A kind of preparation method of Duo substituted oxazoles derivative
CN108947877A (en) A kind of chiral beta-hydroxy sulfone and preparation method thereof
CN108148069A (en) A kind of synthetic method of furanone and pyridine compounds
CN111574413A (en) A kind of preparation method of sulfonyl amidine with 2-aminomethylpyridine and DMF-DMA as amine source
CN111763222A (en) Intermediate for preparing edoxaban free base and preparation method and application thereof
CN108003086A (en) A kind of preparation method of 3- amidos -2- indole ketone compounds
CN110256493A (en) A kind of C2- phosphono benzazolyl compounds and preparation method thereof
CN105218540A (en) The preparation method of a kind of C-3 position thiocarbamoyl imidazole also [1,2-a] pyridine compounds and their
CN110105274B (en) Synthetic method of 3- (2-amino aryl) quinoline compound
CN111620896A (en) Preparation method of tetra-coordinated N, N-chelated diaryl borate compound with 8-aminoquinoline derivative as bidentate ligand
CN102558095A (en) Method for preparing aromatic amine compound
CN103012502B (en) Heteronuclear iridium gold bicyclo metal compound as well as preparation method and application of compound
CN110790689A (en) A kind of synthetic method of 1,1-difluoro-2-isonitrile-ethylphenyl sulfone compounds
CN110041220A (en) A kind of symmetrical imide analog compounds and its synthetic method
CN106966948B (en) A kind of synthetic method of gem-difluoro substituted pyrrolidone compound
CN110038632B (en) Preparation of a sulfonic acid functionalized lignin heterogeneous catalyst and a method for synthesizing amide compounds using the catalyst
CN113754604B (en) Nitrogen-containing chiral ligand and application thereof in asymmetric oxidation reaction of thioether
CN108503501A (en) A method of synthesis 2- fluoro-N- substituted aryl Carbox amides
CN114853555A (en) Synthesis process of asymmetric disulfide compound
CN107778182A (en) Method for synthesizing N-alkyl arylamine
CN109438299B (en) Method for synthesizing benzenesulfonyl enamine compound from benzenesulfonyl hydrazide derivative and triethylamine under metal-free catalysis
CN110078661B (en) A kind of preparation method of 3-alkenyl-2,2'-bipyridine-6-carboxamide derivative

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant